Skip to Main Content

Paper Details

Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children's Oncology Group (COG) New Agents for Ewing Sarcoma Task Force.
F1000Res
46
2019
Bone Tumor, CDK4/6, Ewing Sarcoma, Ewing sarcoma, PARP, cyclin-dependent kinase 4 and 6, dinutuximab, eribulin, patients, poly, poly-ADP-ribose, poly-ADP-ribose polymerase, small, small round blue cell malignancy, tyrosine, tyrosine kinase
Author NameAffiliation
Patrick J GroharVan Andel Institute, Helen De Vos Children's Hospital and Michigan State University
Patrick J GroharVan Andel Institute, Helen De Vos Children's Hospital and Michigan State University
Peter J HoughtonGreehey Children's Cancer Research Institute, University of Texas Health Science Center
Elizabeth StewartSt. Jude Children's Research Hospital
Elizabeth StewartSt. Jude Children's Research Hospital
Jason T YusteinThe Faris D. Virani Ewing Sarcoma Center at the Texas Children's Cancer Center, Baylor College of Medicine
Katherine A JanewayDana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School
Richard GorlickUniversity of Texas MD Anderson Cancer Center
Richard GorlickUniversity of Texas MD Anderson Cancer Center
Stephen L LessnickCenter for Childhood Cancer and Blood Diseases, Research Institute at Nationwide Children's Hospital
Stephen L LessnickThe Ohio State University College of Medicine
Steven G DuBoisDana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School
  • 1 - 12

Datasets